Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1991 Mar;117(2):156–162. doi: 10.1007/BF01613140

Laboratory evaluation during high-dose vitamin A administration: a randomized study on lung cancer patients after surgical resection

Maurizio Infante 1,✉, Ugo Pastorino 1, Giuseppe Chiesa 2, Ezio Bera 2, Paola Pisani 3, Maurizio Valente 1, Gianni Ravasi 1
PMCID: PMC12201897  PMID: 1672530

Abstract

The laboratory findings in patients receiving high-dose vitamin A as adjuvant treatment for stage I lung cancer are here reported. A group of 283 patients were randomized to either treatment with retinyl palmitate (300 000 IU daily for 12 months) or standard followup, and are now evaluable after a median observation period of 28 months. At regular intervals, all the patients underwent a physical examination, chest roentgenogram, blood chemistries, haematological assays, hepatic and renal function tests and determinations of serum triglycerides and cholesterol. Serum transaminase abnormalities were of similar magnitude in cases and controls, whileγ-glutamyltransferase levels were abnormally elevated in 69% of the treated patients compared to 39% of controls (mean values 149 vs 57 IU/l at 24 months,P<0.05). Serum triglyceride concentrations over 150 mg/dl were seen in 74% of treated patients compared to 43% of controls at 12 months, the average concentration was 283 mg/dl compared to 179 mg/dl (P<0.05). Cholesterol levels showed a modest, non-significant rise with time in both groups, and there was no other laboratory evidence of toxicity attributable to vitamin A. Serum retinol and retinol-binding protein, assessed on a limited sample of patients, were higher in the treatment arm (P<0.05) at 12 months. In our experience 300 000 IU/day of retinyl palmitate can be administered as a possible chemopreventive agent with reasonable safety for up to 2 years.

Key words: Vitamin A, Retinyl palmitate, Toxicity, Lung cancer, Chemoprevention, Adjuvant treatment

References

  1. Alberts DS, McDonald L, Edwards L, Peng YM, Xu MJ, Slymen DJ, Earnest DL, Ritenbaugh C (1988) Pharmacokinetics of retinol administered at a chemopreventive level to normal subjects. Cancer Detect Prev 13:55–64 [PubMed] [Google Scholar]
  2. Babb RR, Kieraldo JK (1978) Cirrhosis due to hypervitaminosis A. West J Med 128:244–246 [PMC free article] [PubMed] [Google Scholar]
  3. Bendich A, Langseth L (1989) Safety of vitamin A. Am J Clin Nutr 49:358–71 [DOI] [PubMed] [Google Scholar]
  4. Bertram JS, Kolonel LM, Meyskens FL (1987) Rationale and strategies for chemoprevention of cancer in humans. Cancer Res 47:3012–31 [PubMed] [Google Scholar]
  5. Bollag W (1983) Vitamin A and retinoid: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1860–3 [DOI] [PubMed]
  6. Comstock GW, Menkens MS, Shober SE, Vuilleumier JP, Helsing KJ (1987) Serum levels of retinol, beta-carotene and alpha-tocopherol in older adults. Am J Epidemiol 127:114–123 [DOI] [PubMed] [Google Scholar]
  7. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouelette VL (1989) How often is medication taken as prescribed? JAMA 261:3273–3277 [PubMed] [Google Scholar]
  8. De Ruyter MG, De Leenher AP (1976) Determination of serum retinal values (vitamin A) by high speed liquid chromatography. Clin Chem 22:1593–1595 [PubMed] [Google Scholar]
  9. DeWitt S, Goodman GE (1981) Vitamin A transport and the mechanism of vitamin A toxicity. In Orfanos CE et al. (eds) Retinoids — advances in basis research and therapy. Springer, Berlin Heidelberg New York, pp 31–39 [Google Scholar]
  10. DeWys WD (1985) Chemoprevention clinical trials. Proceedings of the Symposium on chemoprevention. IASLC —Aug 25–30, 1985; IV World Conference on Lung Cancer, Lung Cancer 11:17–18 [Google Scholar]
  11. Garry PJ, Hunt WC, Bandrofchak JL, VanderJagt D, Goodwin JS (1987) Vitamin A intake and plasma retinol levels in healthy elderly men and women. Am J Clin Nutr 46:989–94 [DOI] [PubMed] [Google Scholar]
  12. Goerz G, Orfanos CE (1978) Systemic treatment of psoriasis with a new aromatic retinoid. Dermatologica 157[Suppl 1]:38–44 [PubMed] [Google Scholar]
  13. Gollnick H (1981) Elevated levels of triglycerides in patients with skin diseases treated with oral aromatic retinoid. The significance of risk factors. In: Orfanos CE et al. (eds) Retinoids — advances in basis research and therapy. Springer, Berlin Heidelberg New York, pp 503–505 [Google Scholar]
  14. Goodman GE, Alberts DS, Peng YM, Beaudry J, Einspahr J, Leigh S, Miles NJ, Davis TP, Meyskens FL (1983) Pharmacokinetics and phase I trial of retinol and 13-cis-retinoic acid. Modulation and mediation of cancer by vitamins. Karger, Basel, pp 311–316 [Google Scholar]
  15. Goodman GE, Alberts DS, Peng YM, Beaudry J, Leighand SE, Moon TE (1984) Plasma kinetics of oral retinol in cancer patients. Cancer Treat Rep 68:1125–1133 [PubMed] [Google Scholar]
  16. Kamm JJ, Ashenfelter KO, Ehmann CW (1984) Preclinical and clinical toxicology of selected retinoids. In Sporn MB et al. (eds) The retinoids, vol 2. Academic Press, Orlando, pp 287–326 [Google Scholar]
  17. Kligman AM, Leyden JJ, Mills O (1981) Oral vitamin A (retinol) in acne vulgaris. In: Orfanos CE et al. (eds) Retinoids — advances in basic research and therapy. Springer, Berlin Heidelberg New York, pp 245–53 [Google Scholar]
  18. Korner WF, Vollm J (1975) New aspects of the tolerance of retinol in humans. Int J Vitan Nutr Res 45:363–72 [PubMed] [Google Scholar]
  19. Lacroix A, Bath PV, Karabatsos A, Couture P, Latreille J, Beaulieu R, Bourque M (1987) Plasma levels of retinol in cancer patients supplemented with retinol. Oncology 44:108–114 [DOI] [PubMed] [Google Scholar]
  20. Lippman SM, Kessler JF, Meyskens FL (1987) Retinoids as preventive and therapeutic anticancer agents (part II). Cancer Treat Rep 71:493–515 [PubMed] [Google Scholar]
  21. McLarty J, Yanagihara R, Riley L (1988) Serum triglyceride elevation after chronic low-dose retinol and beta-carotene administration in a cancer prevention trial (abstract). Proceedings of Third International Conference on the Prevention of Human Cancer: Chemoprevention, January 12–15, 1988, Tucson, Arizona
  22. Middleton B, Byers T, Marshall J, Graham S (1986) Dietary vitamin A and cancer — a multisite case-control study. Nutr Cancer 8:107–116 [DOI] [PubMed] [Google Scholar]
  23. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214 [DOI] [PubMed] [Google Scholar]
  24. Nigra TP, Katz RA, Jorgensen H (1981) Elevation of serum triglyceride levels from oral 13-cis-retinoic acid. In: Orfanos CE et al. (eds) Retinoids — advances in basic research and therapy. Springer, Berlin Heidelberg New York, pp 363–369 [Google Scholar]
  25. Norell SA (1979) Improving medication compliance: a randomised clinical trial. Br Med J 2:1031–1033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pastorino U, Pisani P, Berrino F, Andreoli C, Barbieri A, Costa A, Mazzoleni C, Gramegna G, Marubini E (1987) Vitamin A and female lung cancer: a case-control study on plasma and diet. Nutr Cancer 10:171–9 [DOI] [PubMed] [Google Scholar]
  27. Pastorino U, Soresi E, Clerici M, Chiesa G, Belloni PA, Ongari M, Valente M, Ravasi G (1988) Lung cancer chemoprevention with retinol palmitate. Acta Oncol 27:773–782 [DOI] [PubMed] [Google Scholar]
  28. Resasco M, Canobbio L, Trave F, Valenti G, Mazzoni A, Canti G, Boccardo F, Nicolin A (1988) Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patients. Anticancer Res 8:1319–23 [PubMed] [Google Scholar]
  29. Sestili MA (1985) Chemoprevention clinical trials. Problems and solutions. NIH, Publication no. 85-2715
  30. Sporn MB, Newton NL (1979) Chemoprevention of cancer with retinoids. Fed Proc 38:2528–2534 [PubMed] [Google Scholar]
  31. Tamayo L, Ruiz-Maldonado R (1981) Long-term follow-up of 30 children under oral retinoid Ro 10-9359. In: Orfanos CE et al. (eds) Retinoids — advances in basic research and therapy. Springer, Berlin Heidelberg New York, pp 287–294 [Google Scholar]
  32. Wald NJ, Chuckle HS, Barlow RD, Thompson P, Nanchahal K, Blow RJ, Brown I, Harling CC, McCullock WJ, Morgan J, Reid AR (1985) The effect of vitamin A supplementation on serum retinol and retinol binding protein levels. Cancer Lett 29:203–213 [DOI] [PubMed] [Google Scholar]
  33. Willett WC, Stampfer M, Underwood BA, Taylor JO, Hennekens CH (1983) Vitamins A, E and carotene: effects of supplementation on their plasma levels. Am J Clin Nutr 38:559–566 [DOI] [PubMed] [Google Scholar]
  34. Windhorst DB, Nigra T (1982) General clinical toxicology of oral retinoids. J Am Acad Dermatol 6:675–82 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES